drugset / Trial / NCT05996848
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will look at how well the new medicine CagriSema helps people with excess body weight losing weight compared to a "dummy" medicine and a medicine called semaglutide. Participants will either get CagriSema, a dummy medicine or semaglutide. Which treatment participants get is decided by chance. Participants will take one injection once a week. The study medicine will be injected briefly with a thin needle, typically in the stomach, thighs or upper arms. The study will last for about 1 year.
Timeline
- Start
- 2023-08-15
- Primary completion
- 2025-01-06
- Completion
- 2025-02-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cagrilintide | Protein / enzyme biologic | 2.4 mg | Subcutaneous |
| Subject | Semaglutide | Peptide | 2.4 mg | Subcutaneous |